2,993
Views
9
CrossRef citations to date
0
Altmetric
Review

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies

, , & ORCID Icon
Article: 2226922 | Received 25 Feb 2023, Accepted 14 Jun 2023, Published online: 26 Jun 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, Haripriya Gupta, Jin-Ju Jeong, Satya Priya Sharma, Sung-Min Won, Ki-Kwang Oh, Sang Jun Yoon, Hee Jin Park, Jung A Eom, Min Kyo Jeong, Ji Ye Hyun, Nattan Stalin, Tae-Sik Park, Jieun Choi, Do Yup Lee, Sang Hak Han, Dong Joon Kim & Ki Tae Suk. (2024) Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation. Gut Microbes 16:1.
Read now

Articles from other publishers (8)

Jacqueline Wyss, Tina Raselli, Annika Wyss, Anja Telzerow, Gerhard Rogler, Niklas Krupka, Bahtiyar Yilmaz, Thomas S. B. Schmidt & Benjamin Misselwitz. (2024) Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice. BMC Microbiology 24:1.
Crossref
Shujie Xu, Feng Lu, Jianhua Gao & Yi Yuan. (2024) Inflammation‐mediated metabolic regulation in adipose tissue. Obesity Reviews.
Crossref
Xiaobo Wang, Liang Zhang & Bingning Dong. (2024) Molecular mechanisms in MASLD/MASH-related HCC. Hepatology.
Crossref
Xiaofen Qi, Yanfeng Ma, Kaifang Guan, Le Zhao, Ying Ma & Rongchun Wang. (2024) Whey Protein Peptide Pro-Glu-Trp Ameliorates Hyperuricemia by Enhancing Intestinal Uric Acid Excretion, Modulating the Gut Microbiota, and Protecting the Intestinal Barrier in Rats. Journal of Agricultural and Food Chemistry 72:5, pages 2573-2584.
Crossref
Natthaya Chuaypen, Aisawan Asumpinawong, Pattarose Sawangsri, Jakkrit Khamjerm, Nutta Iadsee, Thananya Jinato, Sawannee Sutheeworapong, Suthep Udomsawaengsup & Pisit Tangkijvanich. (2024) Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index. International Journal of Molecular Sciences 25:3, pages 1807.
Crossref
Jia Wei, Jiayou Luo, Fei Yang, Wen Dai, Xiongfeng Pan & Miyang Luo. (2024) Identification of commensal gut bacterial strains with lipogenic effects contributing to NAFLD in children. iScience 27:2, pages 108861.
Crossref
Snigdha Jyoti Das, Sangit Dutta, Diptika Tiwari, Tarun Kr Basumatary, Natasha Kashyap, Manash Pratim Kalita, Sujoy Bose & Purabi Deka Bose. (2024) Prognostic value of myeloid differentiation primary response protein 88 in type II diabetes mellitus in non-obese NAFLD: A case-control study from Assam. Human Gene 39, pages 201246.
Crossref
Zhitao Chen, Weiguang Shi, Kailei Chen, Chicheng Lu, Xinyuan Li & Qiyong Li. (2023) Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis. Frontiers in Microbiology 14.
Crossref